Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-26 @ 6:42 PM
Study NCT ID:
NCT05990192
Status:
RECRUITING
Last Update Posted:
2025-04-22
First Post:
2023-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Sponsor:
Institute of Cancer Research, United Kingdom
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-21
First Submit QC Date:
None
Study First Post Date:
2023-08-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-17
Last Update Post Date:
2025-04-22
Last Update Post Date Type:
ACTUAL